VRTX

Vertex Pharmaceuticals Inc

Jun 22 • 04:00PM ET

466.79

+15.16 3.36 %

Healthcare • Biotechnology • USA • Large • NASD

Peers: REGN AMGN GILD BIIB ALNY ABBV ARGX LLY MRK BMRN

| Held by: VTI VOO QQQ IVV SPY VUG XLV IBB JEPI QQQM

Scroll to Statements

Index	NDX, S&P 500	P/E	27.67	EPS (ttm)	16.87	Insider Own	0.24%	Shs Outstand	254.16M	Perf Week	4.91%
Market Cap	118.47B	Forward P/E	21.59	EPS next Y	21.62	Insider Trans	-22.66%	Shs Float	253.19M	Perf Month	8.44%
Enterprise Value	113.20B	PEG	2.01	EPS next Q	4.72	Inst Own	95.52%	Short Float	1.77%	Perf Quarter	2.82%
Income	4.34B	P/S	9.60	EPS this Y	4.92%	Inst Trans	-1.14%	Short Ratio	3.51	Perf Half Y	3.84%
Sales	12.34B	P/B	6.13	EPS next Y	11.98%	ROA	17.58%	Short Interest	4.49M	Perf YTD	2.96%
Book/sh	76.18	P/C	16.32	EPS next 5Y	10.76%	ROE	24.20%	52W High	507.92 -8.10%	Perf Year	5.88%
Cash/sh	28.60	P/FCF	31.93	EPS past 3/5Y	6.12% 8.28%	ROIC	20.32%	52W Low	362.50 28.77%	Perf 3Y	34.07%
Dividend Est.	-	EV/EBITDA	22.05	Sales past 3/5Y	11.34% 14.23%	Gross Margin	86.38%	Volatility	3.17% 2.46%	Perf 5Y	147.15%
Dividend TTM	-	EV/Sales	9.17	EPS Y/Y TTM	546.48%	Oper. Margin	39.85%	ATR (14)	12.06	Perf 10Y	447.75%
Dividend Ex-Date	-	Quick Ratio	2.57	Sales Y/Y TTM	11.75%	Profit Margin	35.15%	RSI (14)	63.64	Recom	1.50
Dividend Gr. 3/5Y	- -	Current Ratio	3.02	EPS Q/Q	61.58%	SMA20	5.14%	Beta	0.30	Target Price	553.64
Payout	0.00%	Debt/Eq	0.10	Sales Q/Q	9.70%	SMA50	6.46%	Rel Volume	1.59	Prev Close	451.63
Employees	6400	LT Debt/Eq	0.10	Earnings	May 04 AMC	SMA200	6.09%	Avg Volume	1.28M	Price	466.79
IPO	Jul 24, 1991	Option/Short	Yes / Yes	EPS/Sales Surpr.	5.35% -0.24%	Trades		Volume	2,034,196	Change	3.36%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)